Sly Saint
Senior Member (Voting Rights)
Trial By Error: My Letter to Professor Moss-Morris
http://www.virology.ws/2020/02/03/trial-by-error-my-letter-to-professor-moss-morris/
Last week I wrote about the recently announced licensing deal between Mahana Therapeutics and King’s College London. The deal involves a web-based course of cognitive behavior therapy designed to treat irritable bowel syndrome. In a major study, the reported improvements in symptoms among participants in the web-based program were modest at best. Yet Mahana is promoting these improvements as “dramatic” and “potentially game-changing for patients.”
On Monday, I e-mailed Mahana Therapeutics with a few questions. I have not heard back, although I followed up my initial e-mail with two nudges. On Friday, I sent the following e-mail to Professor Rona Moss-Morris, the study’s co-investigator. (Professor Moss-Morris has stock options in the company and has received payment as a consultant.).
http://www.virology.ws/2020/02/03/trial-by-error-my-letter-to-professor-moss-morris/